These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 21446974)

  • 1. Chronic calcineurin inhibitor nephrotoxicity-lest we forget.
    Chapman JR
    Am J Transplant; 2011 Apr; 11(4):693-7. PubMed ID: 21446974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity.
    Flechner SM; Kobashigawa J; Klintmalm G
    Clin Transplant; 2008; 22(1):1-15. PubMed ID: 18217899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
    Tönshoff B; Höcker B
    Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras.
    Nankivell BJ; PʼNg CH; OʼConnell PJ; Chapman JR
    Transplantation; 2016 Aug; 100(8):1723-31. PubMed ID: 27306529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence.
    Issa N; Kukla A; Ibrahim HN
    Am J Nephrol; 2013; 37(6):602-12. PubMed ID: 23796509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is arteriolar vacuolization a predictor of calcineurin inhibitor nephrotoxicity?
    Horike K; Takeda A; Yamaguchi Y; Ogiyama Y; Yamauchi Y; Murata M; Kawaguchi T; Suzuki T; Otsuka Y; Inaguma D; Goto N; Watarai Y; Uchida K; Morozumi K
    Clin Transplant; 2011 Jul; 25 Suppl 23():23-7. PubMed ID: 21623910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of histological markers of long-term CNI nephrotoxicity in kidney-transplant recipients under low-dose cyclosporine therapy.
    Snanoudj R; Royal V; Elie C; Rabant M; Girardin C; Morelon E; Kreis H; Fournet JC; Noël LH; Legendre C
    Am J Transplant; 2011 Dec; 11(12):2635-46. PubMed ID: 21883915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term clinicopathological impact of calcineurin inhibitor cessation without specific cytoreductive induction in kidney transplantation.
    Tanabe T; Morita K; Fujita H; Hatanaka K; Ogawa Y; Hirose T; Sasaki H; Iwami D; Hotta K; Nonomura K
    Clin Transplant; 2013; 27 Suppl 26():9-13. PubMed ID: 24299230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nephrotoxicity of calcineurin inhibitors: presentation, diagnostic problems and risk factors].
    Snanoudj R; Rabant M; Royal V; Pallet N; Noël LH; Legendre C
    Nephrol Ther; 2009 Dec; 5 Suppl 6():S365-70. PubMed ID: 20129447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations of current liver transplant immunosuppressive regimens: renal considerations.
    Zhang W; Fung J
    Hepatobiliary Pancreat Dis Int; 2017 Feb; 16(1):27-32. PubMed ID: 28119255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacogenetics of calcineurin inhibitor-related nephrotoxicity.
    Hesselink DA; Bouamar R; van Gelder T
    Ther Drug Monit; 2010 Aug; 32(4):387-93. PubMed ID: 20571464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiological mechanisms of calcineurin inhibitor-induced nephrotoxicity and arterial hypertension.
    Hošková L; Málek I; Kopkan L; Kautzner J
    Physiol Res; 2017 May; 66(2):167-180. PubMed ID: 27982677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid and calcineurin inhibitor-sparing protocols in kidney transplantation.
    Helal I; Chan L
    Transplant Proc; 2011 Mar; 43(2):472-7. PubMed ID: 21440737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and clinical determinants of early, acute calcineurin inhibitor-related nephrotoxicity: results from a kidney transplant consortium.
    Jacobson PA; Schladt D; Israni A; Oetting WS; Lin YC; Leduc R; Guan W; Lamba V; Matas AJ;
    Transplantation; 2012 Mar; 93(6):624-31. PubMed ID: 22334041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcineurin inhibitors and nephrotoxicity in children.
    Liu F; Mao JH
    World J Pediatr; 2018 Apr; 14(2):121-126. PubMed ID: 29532435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The over-exaggerated chronic nephrotoxicity of calcineurin inhibitors.
    Issa N; Kukla A; Ibrahim HN
    Arab J Urol; 2012 Jun; 10(2):169-74. PubMed ID: 26558021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased acute rejection and improved renal allograft survival using sirolimus and low-dose calcineurin inhibitors without induction therapy.
    Tsai MK; Wu FL; Lai IR; Lee CY; Hu RH; Lee PH
    Int J Artif Organs; 2009 Jun; 32(6):371-80. PubMed ID: 19670189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study on renal biopsy before and after long-term calcineurin inhibitors therapy: an insight for pathogenesis of its toxicity.
    Singh L; Singh G; Sharma A; Sinha A; Bagga A; Dinda AK
    Hum Pathol; 2015 Jan; 46(1):34-9. PubMed ID: 25449629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?
    Höcker B; Tönshoff B
    Paediatr Drugs; 2011 Feb; 13(1):49-69. PubMed ID: 21162600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monitoring of calcineurin inhibitors induced-nephrotoxicity].
    Kamar N; Rostaing L
    Nephrol Ther; 2008 Jun; 4 Suppl 1():S13-S17. PubMed ID: 18703392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.